We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.66%
2 Healthcare 21.01%
3 Consumer Discretionary 11.38%
4 Communication Services 10.4%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
176
JPMorgan Chase
JPM
$953B
$275K 0.01%
1,765
+426
+32% +$66.9K
CCI icon
177
Crown Castle
CCI
$32.3B
$271K 0.01%
1,391
-199
-13% -$37.3K
FDX icon
178
FedEx
FDX
$76.3B
$258K 0.01%
865
– –
AMD icon
179
Advanced Micro Devices
AMD
$780B
$256K 0.01%
2,728
-1,525
-36% -$123K
GM icon
180
General Motors
GM
$77B
$254K 0.01%
4,297
– –
TJX icon
181
TJX Companies
TJX
$145B
$254K 0.01%
3,762
– –
LVS icon
182
Las Vegas Sands
LVS
$28.7B
$247K 0.01%
4,680
-170,627
-97% -$9.85M
MRSH
183
Marsh
MRSH
$88.6B
$244K 0.01%
1,734
– –
EQIX icon
184
Equinix
EQIX
$102B
$242K 0.01%
302
– –
DE icon
185
Deere & Co
DE
$187B
$240K 0.01%
680
+297
+78% +$108K
CL icon
186
Colgate-Palmolive
CL
$70.8B
$238K 0.01%
2,930
– –
ILMN icon
187
Illumina
ILMN
$33B
$236K 0.01%
513
– –
USB icon
188
US Bancorp
USB
$98.7B
$232K 0.01%
4,065
-716
-15% -$42K
EL icon
189
Estee Lauder
EL
$37.6B
$226K 0.01%
710
– –
BFAM icon
190
Bright Horizons
BFAM
$3.42B
$224K 0.01%
1,526
+381
+33% +$57K
TFC icon
191
Truist Financial
TFC
$63.1B
$223K 0.01%
4,023
-734
-15% -$43.1K
DDOG icon
192
Datadog
DDOG
$76.5B
$222K 0.01%
2,129
-380
-15% -$34.3K
EW icon
193
Edwards Lifesciences
EW
$51.8B
$219K 0.01%
2,116
– –
ICE icon
194
Intercontinental Exchange
ICE
$90.5B
$219K 0.01%
1,842
– –
SHW icon
195
Sherwin-Williams
SHW
$81B
$218K 0.01%
801
– –
BILL icon
196
BILL Holdings
BILL
$4.19B
$217K 0.01%
1,185
+227
+24% +$35.6K
MELI icon
197
Mercado Libre
MELI
$100B
$213K 0.01%
137
-26
-16% -$38.2K
D icon
198
Dominion Energy
D
$57.9B
$211K 0.01%
2,872
– –
BSX icon
199
Boston Scientific
BSX
$69.3B
$203K 0.01%
4,759
+2,038
+75% +$85.7K
EMR icon
200
Emerson Electric
EMR
$85.2B
$203K 0.01%
2,109
– –
6 7
8
9 10

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.